Sandoz starts enrolment in biosimilar denosumab trial

Osteoporosis is a bone disease where there is reduced bone mineral density (R), increasing the likelihood of fractures. Credit: www.scientificanimations.com.



  • Sandoz starts enrolment in biosimilar denosumab trial